MIKAYLA POLITES: Open Payments
NPI 1447032040 · EBENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 32 payments from 10 companies in 2025. Trend: 2023 $14 · 2024 $204 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $135 |
| Ardelyx, Inc. | 4 | $99 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $66 |
| Novo Nordisk Inc | 3 | $57 |
| PFIZER INC. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| Verona Pharma, Inc. | 1 | $17 |
Products named: IBSRELA, UBRELVY, XIFAXAN, QULIPTA, Ozempic, VOQUEZNA, AIRSUPRA, ELIQUIS.
Industry payments across PA — which companies pay providers there.
